Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 5.72106 | 81 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 5.75273 | 80 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 5.63828 | 80 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 6.2256 | 83 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 5.8791 | 81 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.71431 | 74 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.31951 | 69 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 5.62484 | 80 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 6.01395 | 83 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 5.89702 | 81 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 5.49799 | 79 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 5.86487 | 81 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 5.96386 | 82 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 5.87993 | 82 |